glp-1 receptor agonists in pediatric and adolescent obesity prescribing among teens with Emerging Frontiers in GLP-1 Therapeutics:

By 1989 the Copehnagen researchers had managed to complete the full sequence for porcine peptide and confirmed the sequence for the human peptide originally predicted by Bell in 1983

Haadia Waheed, orcid.org/0009-0005-4387-1580

Gromada, J., Holst, J

Gupta NA, Kolachala VL, Jiang R, Abramowsky C, Romero R, Fifadara N, et al

In this narrative literature review, we explore the pharmacological properties of tirzepatide and critically summarize and comment on the results of the clinical studies conducted thus far, as well as discuss the potential implications for the treatment of obesity, T2DM, and associated cardiometabolic complications

The prospect of having a new medication to treat multiple chronic conditions is exciting, but more research is still needed